Nova Wealth Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Nova Wealth Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.42K	Buy	+42	New	+$1.4K	﹤0.01%	536

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harel Insurance Investments & Financial Services Ramat Gan, Israel $21.3B AUM 44.31% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.8B AUM 42.86% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $59.1B AUM 41.96% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Migdal Insurance & Financial Holdings Petach Tikva, Israel $16.3B AUM 54.64% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Lingotto Investment Management London, United Kingdom $5.74B AUM 42.24% 1-Year Est. Return

Nova Wealth Management's TEVA Position: Q2 2026 in Review

Nova Wealth Management opened a new position in Teva Pharmaceutical Industries Limited (TEVA) in Q2 2026: 42 shares worth $1.42K. The stake represents ﹤0.01% of the portfolio and ranks #536 among its holdings.

679 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Nova Wealth Management held 42 shares of Teva Pharmaceutical Industries Limited worth $1.42K as of Q2 2026.
Teva Pharmaceutical Industries Limited was a new Nova Wealth Management position in Q2 2026.
Teva Pharmaceutical Industries Limited made up ﹤0.01% of Nova Wealth Management's portfolio in Q2 2026, its #536 holding.
679 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Nova Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.